| Lauren Grell, SLP | |
|
8301 161st Ave Ne Ste 208, Redmond, WA 98052-3858 | |
| (425) 882-4347 | |
| Not Available |
| Full Name | Lauren Grell |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 8301 161st Ave Ne Ste 208, Redmond, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790390417 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL61088996 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lauren Grell, SLP 8301 161st Ave Ne Ste 208, Redmond, WA 98052-3858 Ph: () - | Lauren Grell, SLP 8301 161st Ave Ne Ste 208, Redmond, WA 98052-3858 Ph: (425) 882-4347 |
News Archive
Two independent groups of researchers led by Sidney (Wally) Whiteheart, PhD, of the University of Kentucky, and Charles Lowenstein, MD, of the University of Rochester, have published important studies exploring the role that a gene called STXBP5 plays in the development of cardiovascular disease.
According to a report released by the Institute of Medicine Wednesday, nearly a third of Americans experience long-lasting pain and too often feel stigma rather than relief from a health care system poorly prepared to treat them. Chronic pain is costing the nation at least $558 billion a year in medical bills, sick days and lost productivity, the report found. That's more than the cost of heart disease, the top killer.
Max Planck Innovation licenses analysis-technology for metabolites . Max Planck Innovation GmbH, the technology transfer organization of the Max Planck Society, has awarded an exclusive license for the analysis software TagFinder to Metabolomic Discoveries GmbH, a service provider in biochemical research.
Vertex Pharmaceuticals Incorporated announced today that holders of its 4.75% Convertible Senior Subordinated Notes due 2013 have agreed to exchange approximately $109.0 million in aggregate principal amount of those notes and accrued interest for approximately 4.8 million shares of the Company's common stock, which is approximately 140,000 shares more than the number of shares into which the notes were convertible under their original terms.
› Verified 5 days ago
Ms. Constance Essinger, M.ED. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17272 Ne 104th St, Redmond, WA 98052 Phone: 425-936-1800 Fax: 425-936-1810 | |
Peregrine Therapy, Pllc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16770 Ne 79th St Ste 105, Redmond, WA 98052 Phone: 425-689-8570 Fax: 425-689-7521 | |
Maivy Ho, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 8301 161st Ave Ne Ste 208, Redmond, WA 98052 Phone: 425-882-4347 Fax: 425-883-0043 | |
Julie M Horace Carlson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8301 161st Ave Ne, #203, Redmond, WA 98052 Phone: 425-882-4347 Fax: 425-883-0043 | |
Kristen Leucuta, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 15325 Redmond Way Apt I2101, Redmond, WA 98052 Phone: 630-946-9026 | |
Sarah Summer Mckim Thomas, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16720 Redmond Way Ste G, Redmond, WA 98052 Phone: 206-486-2906 Fax: 509-821-9219 | |
Colette Moss, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5606 159th Pl Ne, Redmond, WA 98052 Phone: 425-883-3730 |